Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46
Published March 7, 2018 · Recall initiated: January 12, 2018
Summary
FDA records drug Class I recall D-0574-2018, published March 7, 2018 and initiated January 12, 2018. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 6,072 bags; Lot: Lot CLF160003, exp May 2018. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; contains visible particulate matter identified as mold.
What to do
Voluntary: Firm initiated · Press Release
Get an email if LEVOFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOFLOXACIN
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Nationwide
- UPC
- 0355150244478
- Lot
- Lot CLF160003, exp May 2018
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevofloxacin Tablets, 500 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6352-61June 15, 2022
- FDALevofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) 24x100 mL Single Dose FlexibleJune 2, 2021
- FDALevofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDCOctober 3, 2018
- FDALevofloxacin Injection in 5% Dextrose, 750 mg (5 mg/mL), 750 mg in 150 mL 5% Dextrose, 150 mL Single UseAugust 15, 2018
- FDAGERICARE Eyewash, sterile eye irrigating solution, packaged in a 4 fl oz (118 mL) bottle, OTC, Distributed byMarch 7, 2018
- FDASourdough Baguette: Product number 2064; SKU 61659798; GTIN [00046567600949]; UPC 831 49000064 20 pieces;March 7, 2018
Questions about this recall
Was Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46 recalled?
Yes. FDA published recall D-0574-2018 on March 7, 2018. Reported hazard: Presence of Particulate Matter; contains visible particulate matter identified as mold.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOFLOXACIN. UPC: 0355150244478.